tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eliana Merle, 142 are a BUY (79.78%), 36 are a HOLD (20.22%).
Analyst Eliana Merle, currently employed at BARCLAYS, carries an average stock price target met ratio of 51.66% that have a potential upside of 51.61% achieved within 239 days. Previously, Eliana Merle worked at UBS.
Eliana Merle’s has documented 349 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 28-Jan-2026.
Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ANAB (ANAPTYSBIO) at 11/7/2019. The price target of $28 was fulfilled within 1 day with a profit of $8.16 (22.57%) receiving and performance score of 225.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Jan-2026
$24
$2.3 (10.60%)
$44
17 days ago
(28-Jan-2026)
5/11 (45.45%)
$0.93 (4.03%)
391
Buy Since 21-Jan-2026
$28
$6.3 (29.03%)
$24
24 days ago
(21-Jan-2026)
5/11 (45.45%)
$7.05 (33.65%)
29
Buy Since 15-Oct-2025
$26
$4.3 (19.82%)
$32
25 days ago
(20-Jan-2026)
10/15 (66.67%)
$5.53 (27.02%)
72
Buy Since 01-Apr-2020
$35
$13.3 (61.29%)
$39
1 months 1 days ago
(13-Jan-2026)
2/19 (10.53%)
$13.67 (64.09%)
570
Buy Since 19-Nov-2020
$28
$6.3 (29.03%)
$29
1 months 1 days ago
(13-Jan-2026)
11/21 (52.38%)
$6.67 (31.27%)
225
Which stock is Eliana Merle is most bullish on?
Which stock is Eliana Merle is most reserved on?
What Year was the first public recommendation made by Eliana Merle?
